title: Adjustable release of mitomycin C for inhibition of scar tissue formation after filtration surgery.
abstract: The aim of this study is to demonstrate a drug delivery system with the capacity to adjust the release of mitomycin C (MMC), based on polymer composition, and inhibit fibroblast proliferation to a better effect than is currently used in glaucoma filtration surgery. The polymer used in this work is made from the oligosaccharide cyclodextrin, from which others and we have demonstrated adjustable release of small molecule drugs due to specific molecular interactions or "affinity" between drug and the cyclodextrin polymer. To adjust release rate, cyclodextrin polymers were synthesized in either dimethylformamide (DMF) or dimethyl sulfoxide, (DMSO) at a crosslinking ratio of 1:0.16 or 1:0:32 (molecule of glucose: molecule of crosslinker). The polymers were then loaded with mitomycin C, dried, and release evaluated in a physiological environment. Drug release was determined by visible spectroscopy. Released aliquots of mitomycin C were incubated with 3T3 fibroblast cells to determine cytotoxic or inhibitory effect through a cell proliferation assay. We show that by using affinity between drug and polymer, we can adjust MMC release rates to be slower and more sustained than from conventional, diffusion-only polymers, for both the DMF polymers (p = 0.00526) and the DMSO polymers (p = 0.0113). The incorporated and released MMC maintains inhibition of fibroblast proliferation much longer than is possible with a one-time application. Affinity polymers with 1:0.16 and 1:0.32 crosslink ratio showed significant inhibition of proliferation for up to 100 h (p = 0.018 and p = 0.014 respectively). The use of our controlled drug delivery technology applied after surgery could have a greater therapeutic impact than the current one-time applications of MMC.
authors.affiliation: Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, United States.
authors.forename: Sonia R
authors.initials: SR
authors.lastname: Merritt
authors.forename: Gia
authors.initials: G
authors.lastname: Velasquez
authors.forename: Horst A
authors.initials: HA
authors.lastname: von Recum
mesh_terms: D049109:Cell Proliferation / Q000187:drug effects; D002921:Cicatrix / Q000473:pathology / Q000517:prevention & control*; D016503:Drug Delivery Systems; D018463:Filtering Surgery; D005901:Glaucoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage*; D011108:Polymers
chemical_list: D011108:Polymers; D016685:Mitomycin
keywords: CD; IOP; MMC; anti-proliferative; controlled release; cyclodextrin; drug delivery; filtration surgery; glaucoma; intraocular pressure; mitomycin; mitomycin C; sustained release
references.citation: Graefes Arch Clin Exp Ophthalmol. 2003 Feb;241(2):106-10
references.pmid: 12605264
references.citation: Ophthalmology. 1998 Oct;105(10):1915-20
references.pmid: 9787364
references.citation: Pharm Weekbl Sci. 1988 Oct 14;10(5):207-12
references.pmid: 3205677
references.citation: J Ocul Pharmacol Ther. 1995 Fall;11(3):233-41
references.pmid: 8590255
references.citation: J Pharm Biomed Anal. 1991;9(10-12):1055-60
references.pmid: 1822173
references.citation: Adv Drug Deliv Rev. 2008 Jun 10;60(9):1000-17
references.pmid: 18413280
references.citation: Ophthalmology. 1992 Feb;99(2):203-7
references.pmid: 1553208
references.citation: Ophthalmology. 1992 Nov;99(11):1647-54
references.pmid: 1454338
references.citation: Invest Ophthalmol Vis Sci. 2012 May 04;53(5):2491-4
references.pmid: 22562849
references.citation: Biomaterials. 2010 Mar;31(8):2335-47
references.pmid: 20022369
references.citation: Clin Ophthalmol. 2009;3:81-7
references.pmid: 19668548
references.citation: Invest Ophthalmol Vis Sci. 1997 Jul;38(8):1639-46
references.pmid: 9224294
references.citation: Eur J Pharm Sci. 2012 Aug 15;46(5):357-66
references.pmid: 22406092
references.citation: Clin Exp Ophthalmol. 2011 Sep-Oct;39(7):658-64
references.pmid: 22452683
references.citation: Acta Biomater. 2010 Feb;6(2):486-93
references.pmid: 19619677
references.citation: Macromol Biosci. 2011 Mar 10;11(3):321-32
references.pmid: 21108454
references.citation: J Glaucoma. 2002 Feb;11(1):17-20
references.pmid: 11821684
references.citation: Macromol Biosci. 2011 Nov 10;11(11):1544-52
references.pmid: 22167873